BMEZ - BMEZ: Higher Risk Healthcare Exposure With Potential For Higher Reward
2024-03-20 11:40:18 ET
Summary
- BlackRock Health Sciences Term Trust has seen its discount narrow somewhat since our last update, but it remains attractive still.
- BMEZ utilizes a covered call writing strategy and also provides some private investments to help deliver performance.
- The biotech space has performed rather poorly in the last several years but 2024 seems to be a bit more promising.
Written by Nick Ackerman, co-produced by Stanford Chemist.
BlackRock Health Sciences Term Trust ( BMEZ ) has seen its discount to net asset value narrow some from our last update, though the discount still looks appealing today. The biotech space, which comprises a significant portion of BMEZ's portfolio, has been performing better so far to start 2024. However, that was after significant losses in most of the last three years, where the biotech space saw significant declines overall.
Besides the healthcare portfolio that BMEZ invests in, they also utilize a covered call writing strategy and invest in private investments to help differentiate the fund....
BMEZ: Higher Risk Healthcare Exposure With Potential For Higher Reward